CURRICULUM VITAE

Douglass F. Taber
Department of Chemistry
University of Delaware
Newark, DE 19716
(302) 831-2433
FAX: (302) 831-6335
email: Taberdf@udel.edu
Web: valhalla.chem.udel.edu

Home Address:

717 Harvard Lane
Newark, DE 19711
(302) 368-5668

Date and Place of Birth: November 11, 1948; Berkeley, CA

Marital Status: Married, six children

Education:

1970 B.S. Stanford University (Honors in Chemistry)

1974 Ph.D. Columbia University (Organic Chemistry)

Research Interests:

1969-70 Undergraduate Research, L. J. Altman, Stanford University: Preparation of 9,10-cyclopentaphenanthrene; Preparation and reactions of 1,1-dihaloepoxides.

1970-74 Graduate Research, G. Stork, Columbia University: Intramolecular Michael reactions to produce cis-fused bicyclic systems; Applications to the synthesis of gibberellins.

1974-75 Postdoctoral Research, B. M. Trost, University of Wisconsin: Applications of sulfonium chemistry to natural products synthesis.

1975- Current Research: Stereoselective synthesis of natural products; New methods in synthetic organic chemistry; Computational organometallic chemistry in organic synthesis.

Professional Experience:

1974-75 Research Associate, Department of Chemistry, University of Wisconsin

1975-77 Research Instructor, Department of Pharmacology, Vanderbilt University

1977-82 Assistant Professor, Department of Pharmacology, Vanderbilt University

1978-82 Research Assistant Professor, Department of Chemistry, Vanderbilt University

1982-84 Assistant Professor, Department of Chemistry, University of Delaware

1984-93 Associate Professor, Department of Chemistry, University of Delaware

1993- Professor, Department of Chemistry, University of Delaware

Professional Service:

1985 NCI SBIR Study Section, May 1985

1985 Chairman, Local Organizing Committee, 29th National Organic Chemistry Symposium, Newark, DE, June 1985

1984-87 Consultant, Helix Associates, Newark, DE (2 days/year)

1982- Consultant, Division of Clinical Pharmacology, Vanderbilt University (5 days/year)

1985-88 Invited monthly column, "Organic Chemistry Review," Industrial Chemist

1987- Wallace Carothers Award Committee, Delaware Section, American Chemical Society

1988-89 Visiting Research Scientist, Du Pont Central Research

1991 NIH SBIR Study Section, July 1991

1991 State Department/AID Review Panel, Oct 1991

1992 Visiting Professor, Universidad Autonoma Nuevo Leon, Monterrey, Mexico June 7-13

1992 Ad Hoc member, Medicinal Chemistry A Study Section, NIH Oct 14-16

1993 Member, Medicinal Chemistry Special Study Section, NIH, Nov 30

1992-93 Expert witness, Phoenix Petroleum, King of Prussia, PA

1993-94 Expert witness, Rothwell, Figg, Ernst and Kurz, Washington, D.C.

1995 Consultant, Bausch & Lomb Pharmaceuticals, Tampa, Florida

1995- Consultant, Dupont Company

1995-96 Visiting Research Scientist, Dupont Merck Pharmaceuticals

1996 Symposium Organizer, Guided Inquiry in the Organic Lecture and Laboratory, 14th Biennial Conference on Chemical Education, Clemson University

1998 Member, Fellowship Review Panel, NIH, March 23-24th

1998 Symposium Organizer, Practical Applications of Computational Organometallic Chemistry, American Chemical Society National Meeting, Boston, August 26th

2000 Reviewer, National Research Council

2000 Expert Witness, Kenyon & Kenyon, New York, NY

2001 Visiting Professor, South China Agricultural University, Guangzhou, Jan. 6-10.

2001 Short Course, "Intermediate Organic", DuPont Agricultural Chemistry.

2003 Member, Fellowship Review Panel, NIH, July 8-9th

Honors and Awards:

1967-70 Dean's List, Stanford University

1968 NSF Undergraduate Research Participant

1969 Elected to Phi Lambda Upsilon

1970-73 NSF Graduate Fellow

1974 Elected to Sigma Xi

1976-79 Petroleum Research Fund Starter Grant

1977-84 National Institutes of Health Research Grant, CA 34383

1978 Invited participant, National Science Foundation Workshop on Organic Synthesis and Natural Products Chemistry

1979-83 Petroleum Research Fund AC Research Grants

1980-81 Research Grant, Vanderbilt University Research Council

1983-86 National Institutes of Health Research Grant, GM 32027

1983-87 Fellow of the Alfred P. Sloan Foundation

1983 Research Grant, University of Delaware Research Foundation

1983-86 National Science Foundation Research Grant, CHE 8306692

1984 Invited participant, Symposium, "Latest Trends in Organic Synthesis," Blacksburg, VA

1985 National Science Foundation Travel Grant, IUPAC Symposium on Organometallics in Organic Synthesis, Kyoto, Japan

1985-87 Petroleum Research Fund A/C Research Grant

1988 National Science Foundation Travel Grant, IUPAC Symposium on Natural Products Chemistry, Kyoto, Japan

1989 Invited speaker, 5th International Symposium on Carbene Chemistry, Kyoto, Japan

1991 National Science Foundation Travel Grant, IUPAC Symposium on Organometallics in Organic Synthesis, Utrecht

1991-93 Research Grant, Allergan, Inc., Irvine, CA
($50,828/year) one postdoctoral

1991-93 Petroleum Research Fund A/C Research Grant
($20,000/year) one Ph.D. student

1991-93 Research Contract, DoD / Aberdeen, MD
($25,000/first year, $49,600 second year) one Ph.D. student

1991-92 Research Contract, NIH/NIAAA, Bethesda, MD
($25,000/year) one Ph.D. student

1992-95 National Institutes of Health research grant, GM 46762, "Synthesis of Taxol" $171,410 / year, two postdoctorals, one graduate student

1993-2001 National Institutes of Health research grant, GM 42056 "Structural Investigation of Prostaglandin Conjugates", $93,613/year, one postdoctoral

1993 Invited speaker, ACS National Meeting, Denver

1993 National Science Foundation Travel Grant, Joint USA-Japan-China Symposium on Catalysis, Beijing

1993 Invited speaker, Scientific Conference on Chemical Defense Research, Aberdeen, MD

1994 Research Grant, Zeneca Pharmaceuticals, $15,000

1995 Invited speaker, Symposium on Organometallics in Organic Synthesis, 78th Canadian Society for Chemistry Conference and Exhibition

1995-1996 National Science Foundation, GOALI program, $60,000
Sabbatical support

1995-97 Petroleum Research Fund A/C Research Grant
($25,000/year) one Ph.D. student

1996 Invited speaker, 11th International Conference on Organic Synthesis (ICOS-11), Amsterdam

1997 Invited speaker, IUPAC International Conference on Biodiversity and Bioresources, Phuket, Thailand

1998 Invited speaker, Symposium, Practical Applications of Computational Organometallic Chemistry, National American Chemical Society meeting, Boston

  1. Invited speaker, Symposium, "Latest Trends in Organic Synthesis," Gainesville, FL

1999 Invited speaker, Middle Atlantic Regional Meeting, American Chemical Society

1999 Invited speaker, Organometallics in Organic Synthesis (OMCOS 10), Versailles, France July 21st

1999 Invited speaker, Gordon Research Conference on Natural Products, Henniker, NH

1999-2000 Petroleum Research Fund A/C Research Grant ($30,000/year) one Ph.D. student

1999 Invited speaker, South East Regional Meeting, American Chemical Society

2000-2004 National Institutes of Health research grant, GM 60287, "Physiologically Active Natural Products" $215,707 / year, two postdoctorals, one graduate student

2000 Invited speaker, 11th International Conference on Organic Synthesis (ICOS-13), Warsaw

2001 Invited speaker, Organometallics in Organic Synthesis (OMCOS 11), Taipei, Taiwan

Publications:

1. Taber, D. F.: A simple synthesis of 2-alkyl cyclohexenones. J. Org. Chem. 41: 2649, 1976.

2. Trost, B. M.; Taber, D. F.; and Alper, J. B.: An approach to the stereocontrolled creation of an acyclic side chain of some natural products. Tetrahedron Lett.: 3857, 1976.

3. Taber, D. F.: Cyclopentanone ring formation with control of side chain stereochemistry: a simple stereoselective route to the prostaglandins. J. Amer. Chem. Soc. 99: 3513, 1977.

4. Taber, D. F., and Lee, C. H.: The preparation of dimethyl (7-2H3-2-oxoheptyl)phosphonate, a reagent for the synthesis of 20-2H3 prostaglandins and thromboxanes. J. Labelled Compounds and Radiopharmaceuticals 14: 599, 1978.

5. Stork, G.; Taber, D. F.; and Marx, M.: Intramolecular Michael addition as a route to angularly substituted cis hydroindanes. Tetrahedron Lett.: 2445, 1978.

6. Wilson, J. T.; Howell, R. L.; Holladay, M. W.; Brillis, G. M.; Chrastil, H.; Watson, J. T.; and Taber, D. F.: Gentisuric acid (GU): metabolic formation and identification as a metabolite of aspirin in man. Clin. Pharmacol. Ther. 23: 634-643, 1978.

7. Taber, D. F., and Korsmeyer, R.: A simple stereoselective synthesis of (±)-oplopanone. J. Org. Chem. 43: 4925-4927, 1978.

8. Taber, D. F., and Gunn, B. P.: Branching strategy in organic synthesis. A versatile ketone to enone homologation. J. Org. Chem. 44: 450, 1979.

9. Taber, D. F.; Jernigan, J. D.; Watson, J. T.; Carr, K.; and Woosley R. L.: N-Desethylacecainide is a metabolite of procainamide in man: convenient method for the preparation of an N-dealkylated drug metabolite. Drug Metabol. Disp. 7: 346, 1979.

10. Taber, D. F. and Gunn, B. P.: Control elements in the intramolecular Diels-Alder Reaction: synthesis of (±)-torreyol. J. Amer. Chem. Soc. 101: 3992, 1979.

11. Stork, G.; Boeckmann, R. K., Jr.; Taber, D. F.; Still, W. C. and Singh, J.: Reductive cyclization of ethynyl ketones in the construction of a significant tricyclic intermediate for the synthesis of gibberellic acid. J. Amer. Chem. Soc. 101: 7107, 1979.

12. Oates, J. A.; Roberts, L. J., II; Sweetman, B. M.; Maas, R. L.; Gerkens, J. F.; and Taber, D. F.: Metabolism of the prostaglandins and thromboxanes, in: Advances in Prostaglandin and Thromboxane Research, Vol. 6 (B. Samuelsson, P. E. Ramwell and R. Paoletti, Eds.) Raven Press, NY, 1980, p. 35.


13. Verbeeck, R. K.; James, R. C.; Taber, D. F.; Sweetman, B. J.; and Wilkinson, G. R.: The determination of meperidine, normeperidine and deuterated analogs in blood and plasma by gas chromatography mass spectrometry selected ion monitoring. Biomedical Mass Spectrometry 7: 58, 1980.

14. Taber, D. F., and Anthony, J. M.: Stereoselective synthesis of (±)-laurene. Tetrahedron Lett.: 2779, 1980.

15. Taber, D. F., and Saleh, S. A.: Intramolecular Diels-Alder route to angularly substituted perhydrophenanthrenes: synthesis of (±) fichtelite. J. Am. Chem. Soc. 102: 5085, 1980.

16. Taber, D. F.; Saleh, S. A.; and Korsmeyer, R. W.: Preparation of cyclohexanones and cyclopentanones of high optical purity. J. Org. Chem. 45: 4699, 1980.

17. Maas, R.L.; Roberts, L.J.; Taber, D.F.; Oates, J.A. Urinary dinor thromboxane B2 levels in normal males and cardiovascular disease. Clinical Res. 28: A319-A319, 1980.17. Taber, D. F.; Phillips, M. A.; and Hubbard, W. C.: Preparation of deuterated arachidonic acid. Prostaglandins, 22: 349, 1981.

18. Taber, D. F.; Phillips, M. A.; and Hubbard, W. C.: Preparation of deuterated arachidonic acid. Prostaglandins, 22: 349, 1981.

19. Taber, D. F.; Campbell, C.; Gunn, B. P.; Chiu, I.-C.: The intramolecular Diels-Alder reaction: stereocontrol through non-synchronous bond formation? Tetrahedron Lett. 22: 5141, 1981.

20. Taber, D. F., and Saleh, S. A.: Branching strategy in organic synthesis. II: Reversal of olefin polarization with concomitant carbon-carbon bond formation. J. Org. Chem. 46: 4817, 1981.

21. Hubbard, W. C.; Phillips, M. A.; and Taber, D. F.: Selective synthesis of octadeuterated (±) 5-HETE for use in GC-MS quantitation of 5-HETE. Prostaglandins 23: 61, 1982.

22. Taber, D. F.; Phillips, M. A.; and Hubbard, W. C.: Preparation of deuterated arachidonic acid. Methods in Enzymology, Eds. W. E. Lands and W. L. Smith, New York, NY, Academic Press, 1982. V. 86, p. 366.

23. Maas, R. L; Taber, D. F.: and Roberts, L. J., II. Quantitative assay of urinary 2,3-dinor thromboxane B2 by GC-MS. Methods in Enzymology, Eds. W. E. Lands and W. L. Smith, New York, NY, Academic Press, 1982. V. 86, p. 592.

24. Taber, D. F.: TLC mesh column chromatography. J. Org. Chem. 47: 1351, 1982.

25. Taber, D. F., and Saleh, S. A.: Control elements in the intramolecular Diels-Alder reactions: synthesis of a-eudesmol. Tetrahedron Lett. 23: 2361, 1982.

26. Maas, R. L.; Ingram, C. D.; Taber, D. F.; Oates, J. A.; and Brash, A. R.: Stereospecific removal of the R hydrogen atom at the 10-carbon of arachidonic acid in the biosynthesis of leukotriene A by human leukocytes. J.Biol. Chem. 257: 13515, 1982.

27. Taber, D. F., and Petty, E. H.: A general route to highly functionalized cyclopentane derivatives by intramolecular C-H insertion. J. Org. Chem. 47: 4808, 1982.

28. Taber, D. F.; Gunn, B. P.; and Chiu, I.-C.: Preparation of 2-heptyl cyclohexenone. Org. Syn. 61: 59, 1983.

29. Hubbard, W. C., and Taber, D. F.: Analysis of hydroxy acids, Proceedings of the Ninth International School of Pharmacology: Prostacyclins and Leukotrienes, Plenum, 1983.

30. Taber, D. F., and Raman, K.: Enantioselective carbocyclization: a facile route to chiral cyclopentanes. J. Am. Chem. Soc., 105: 5935, 1983.

31. Taber, D. F.; Krewson, K. R.; Raman, K.; and Rheingold, A. L.: On the stereochemical course of cuprate-mediated addition to an activated cyclopropane. Tetrahedron Lett. 25: 5283, 1984.

32. Taber, D. F.; Petty, E. H.; and Raman, K.: Enantioselective ring construction: synthesis of (+)-a-cuparenone. J. Am. Chem. Soc., 107: 196, 1985.

33. Maas, R. L.; Ingram, C. D.; Porter, A. T.; Oates, J. A.; Taber, D. F.; and Brash, A. R.: Investigation of the chemical conversion of hydroperoxyeicosatetraenoate to leukotriene epoxide using stereospecifically labelled arachidonic acid. J. Biol. Chem. 260: 4217, 1985.

34. Taber, D. F.; Dunn, B. S.; Mack, J. F.; and Saleh, S. A.: Ortho allylation of benzyl alcohols. J. Org. Chem. 50: 1987, 1985.

35. Taber, D. F., and Ruckle, R. E., Jr.: Diastereoselection in rhodium-mediated intramolecular C-H insertion: preparation of a trans-3,4-dialkylcyclopentane. Tetrahedron Lett. 26: 3059, 1985.

36. Taber, D. F., and Schuchardt, J. S.: Intramolecular C-H insertion: synthesis of (±)-pentalenolactone E methyl ester. J. Am. Chem. Soc., 107: 5289, 1985.

37. Taber, D. F.; Amedio, J. C., Jr.; and Patel, Y. K.: Preparation of ß-ketoesters by 4-DMAP catalyzed ester exchange. J. Org. Chem. 50: 3618, 1985.

38. Taber, D. F.; Amedio, J. C., Jr.; and Sherrill, R. G.: Pd-mediated diazo insertions: preparation of 3-alkyl 2-carbomethoxy cyclopentenones. J. Org. Chem. 51: 3382, 1986.

39. Taber, D. F.; Ruckle, Robert E., Jr.; Hennessy, Michael J.: Mesyl azide, a superior reagent for diazo transfer. J. Org. Chem. 51: 4077, 1986.

40. Taber, D. F., and Ruckle, Robert E., Jr.: Cyclopentane construction by Rh2(Ac)4-mediated intramolecular C-H insertion: steric and electronic effects. J. Am. Chem. Soc. 108: 7686, 1986.

41. Taber, D. F., Raman, K.and Gaul, M.D.: Enantioselective ring construction: synthesis of (+)-estrone methyl ether. J. Org. Chem. 52: 28, 1987.

42. Taber, D. F. and Schuchardt, J. S.: Symmetry in retrosynthetic analysis: synthesis of pentalenolactone E methyl ester. Tetrahedron 43: 5677, 1987.

43. Prakash, C.; Roberts, L. J. II; Saleh, S. A.; Taber, D. F.; and Blair, I. A. Synthesis of Putative Prostaglandin D2 Metabolites. Advances in Prostaglandin, Thromboxane and Leukotriene Research, Samuelsson, B., Paoletti, R., and Ramswell, P. W., Eds., Raven Press, NY, 1987, V. 17, p. 781.

44. Taber, D. F.; Deker, P. B.; and Gaul, M. D.: Enantioselective construction of dialkyl carbinols: synthesis of (-)-hexadecanolide. J. Am. Chem. Soc. 109, 7488, 1987.

45. Taber, D. F.; Amedio, J. C., Jr.; and Jung, K.-Y.: P2O5/DMSO/Triethylamine (PDT): a convenient procedure for oxidation of alcohols to ketones and aldehydes. J. Org. Chem. 52: 5621, 1987.

46. Taber, D.F.; Deker, P.B.; Fales, H.M.; Jones, T.H.; and Lloyd, H.A.: Enantioselective construction of heterocycles: synthesis of (R,R)-solenopsin B. J. Org. Chem. 53: 2968, 1988.

47. Taber, D. F.; Amedio, J.C., Jr.; Raman, K. Enantioselective ring construction with control of side-chain stereochemistry: synthesis of (+)-isoneonepetalactone. J.Org. Chem. 53: 2984, 1988.

48. Prakash, P.; Saleh, S.; Roberts, L.J. III; Blair, I.A.; Taber, D.F. Synthesis of the major urinary metabolite of prostaglandin D2. J. Chem. Soc. Perkin Trans. I, 1988, 2821.

49. RajanBabu, T. V.; Nugent, W.A.; Taber, D. F.; Fagan, P. J. Stereoselective cyclization of enynes mediated by metallocene reagents. J. Am. Chem. Soc. 110: 7128, 1988.

50. Prakash, C.; Saleh, S.; Sweetman, B. J.; Taber, D. F.; Blair, I. A. A synthon for C-20 trideuterated eicosanoids: Preparation of [2H3]-arachidonic J. Labelled Cmpds. and Radiopharm. XXVII: 539, 1989

51. Taber, D. F.; Amedio, J. C.; Jr.; Gulino, F. Selective decarbalkoxylation of ß-keto esters. J. Org. Chem. 54: 3474, 1989.

52. Taber, D. F. Mack, J. F., Rheingold, A. L. and Geib, S. J. Enantioselective Robinson annulation: synthesis of (+)-O-methyljoubertiamine. J. Org. Chem. 54: 3831, 1989.

53. Nugent, W. A. and Taber, D. F. Zirconium-mediated ring construction from dienes: remarkable effect of ligands on stereochemistry. J. Am. Chem. Soc. 111: 6435, 1989.

54. Prakash, C.; Saleh, S.; Taber, D. F.; Blair, I. A. Synthesis of trideuterated o-alkyl platelet activating factor and lyso derivatives. Lipids 24: 786, 1989.

55. Prakash, C.; Saleh, S.; Taber, D.F.; Blair, I.A. A practical route for the synthesis of prostaglandin D2 metabolites. Syn. Comm. 19: 245, 1989.

56. Nugent, W.A.; RajanBabu, T.V.; Taber, D.F. "One-Electron" vs. "Two-Electron" cyclizations mediated by titanium and zirconium reagents Chemica Scripta 29: 439 (1989).

57. Prakash, C.; Saleh, S.; Taber, D. F.; Wilkinson, Grant R.; Blair, I. A. Deuterium labelling of the antidepressant drug doxepin for disposition studies in human subjects. J. Labelled Cmpds. and Radiopharm. XXVIII: 1037, 1990.

58. Taber, D.F.; Hoerrner, R.S. Column Chromatography: Isolation of Caffeine J. Chem. Ed 68: 73 (1991)

59. Taber, D.F.; Hoerrner, R.S.; Hagen, M.D. A practical preparation of the indolizidine nucleus: Synthesis of (±)-elaeokanine A. J. Org. Chem. 56: 1287, 1991.

60. Taber, D.F.; Silverberg, L.J. Enantioselective reduction of ß-keto esters. Tetrahedron Letters 32: 4227, 1991.

61. Taber, D.F.; Silverberg, L.J.; Robinson, E.D. Cyclopentane construction with control of side-chain configuration: Synthesis of (+)-brefeldin A. J. Am. Chem. Soc. 113: 6639, 1991.

62. Taber, D.F.; Hennessy, M.J.; Louey, J.P. Rh-mediated cyclopentane construction can compete with ß-hydride elimination: Synthesis of (±)-tochuinyl acetate. J. Org. Chem. 57: 436, 1992.

63. Taber, D.F.; Hoerrner, R.S. Enantioselective Rh-mediated synthesis of (-)-PGE2 methyl ester. J. Org. Chem. 57: 441, 1992.

64. Taber, D.F.; Stachel, S.J. On the mechanism of the Wolff-Kishner reduction. Tetrahedron Lett. 33: 903, 1992.

65. Taber, D.F.; Rahimizadeh, M. Amide to ester conversion: A practical route to the carfentanil class of analgetics. J. Org. Chem. 57: 4037, 1992.

66. Taber, D.F.; Deker, P.B.; Silverberg, L.J. Enantioselective Ru-mediated synthesis of (-)-indolizidine 223AB. J. Org. Chem. 57: 5990, 1992.

67. Taber, D.F.; Meagley, R.P. Synthesis of 2-chloroethyl (13C)- methyl sulfide. J. Labelled Cmpds. and Radiopharm. 31: 849, 1992.

68. Taber, D.F. On the attempted synthesis of 3ß-hydroxy-7ß-kemp-8(9)-en-6-one. Tetrahedron Letters 34: 1833, 1993.

69. Taber, D.F.; Louey, J.P.; Lim, J.A. On the reversibility of alkene cyclozirconation. Tetrahedron Letters 34: 2243, 1993.

70. Taber, D.F.; Wang, Y.; Stachel, S.J. Alkyl radical generation by reduction of a ketone tosylhydrazone. Tetrahedron Letters 34: 6209, 1993.

71. Taber, D.F.; Wang, Y. Preparation of 2-chloroethyl-1,1-d2 phenyl sulfide without appreciable scrambling. J. Org. Chem. 58: 6470, 1993.

72. Taber, D.F.; Bhamidipati, R.S.; Thomas, M.L. Cascade cyclization: Synthesis of (+)-tuberine. J. Org. Chem. 59: 3442, 1994.

73. Taber, D.F.; You, K. Synthesis of ethyl w-2H5-docosa-4,7,10,13,16,19-hexaenoate. J. Labelled Cmpds. and Radiopharm. 34: 747, 1994.

74. Taber, D.F.; Houze, J.B. The 2-hydroxycitronellols, convenient chirons for natural products synthesis. J. Org. Chem. 59: 4004, 1994.

75. Taber, D.F.; Walter, R.; Meagley, R.P. Intramolecular C-H insertion by an alkylidene carbene: diastereoselective synthesis of a Taxol A ring synthon. J. Org. Chem. 59: 6014, 1994.

76. Taber. D.F.; Louey, J.P.; Wang, Y.; Nugent, W.A.; Dixon, D.A.; Harlow, R.L. Stereoselectivity in intramolecular diene cyclozirconation: A combined experimental and theoretical approach. J. Am. Chem. Soc. 116: 9457, 1994.

77. Taber, D.F.; Meagley, R.P. Diastereoselectivity in uncatalyzed intramolecular C-H insertion by an alkylidene carbene. Tetrahedron Lett. 35: 7909, 1994.

78. Taber, D.F.; Rahimizadeh, M. Hexasubstituted benzenes by alkyne cyclotrimerization. Tetrahedron Lett. 35: 9139, 1994.

79. Taber, D.F.; You, K. New synthon for the convergent construction of skipped conjugation polyenes: Synthesis of ethyl docosa-4,7, 10, 13, 16, 19-hexaenoate. J. Org. Chem. 60: 139, 1995.

80. Taber, D.F.; Yet, L.; Bhamidipati, R.S. Conversion of phenyldimethylsilyl to the hydroxyl in the presence of a carbon-carbon double bond. Tetrahedron Lett. 36: 351, 1995.

81. Taber, D.F.; Rahimizadeh, M.; You, K.K. Enantioselective synthesis of the Dendrobatid alkaloid (-)-indolizidine 207A. J. Org. Chem. 60: 529 (1995).

82. Taber, D.F.; You, K.; Song, Y. A simple preparation of a-diazo esters. J. Org. Chem. 60: 1093 (1995).

83. Taber, D.F.; Song, Y. 2,3,5-Trisubstituted tetrahydrofurans by Rh-mediated cyclization of an a-diazo ester. Tetrahedron Lett. 36: 2587 (1995).

84. Taber, D.F.; Gleave, D.M.; Herr, R.J.; Moody, K.; Hennessy, M.J. A new method for the construction of a-diazoketones J. Org. Chem. 60: 2283 (1995).

85. Taber, D.F.; Louey, J. P. 1,2-Induction in intramolecular diene cyclozirconation: Control of relative configuration. Tetrahedron 51: 4495 (1995).

86. Taber, D.F.; You, K. Highly diastereoselective cyclopentane construction: Enantioselective synthesis of the dendrobatid alkaloid 251F J. Am. Chem. Soc. 117: 5757 (1995).

87. Taber, D.F.; Wang, Y. Synthesis of (1,2-13C)-2-chloroethyl phenyl sulfide. J. Labelled. Cmpds. and Radiopharm. XXXVI: 655 (1995).

88. Taber, D.F.; Bhamidipati, R.S.; Yet, L. Phenyldimethylsilyl as an alcohol surrogate in intramolecular Diels-Alder cycloaddition: Synthesis of a-dictyopterol. J. Org. Chem. 60: 5537 (1995).

89. Taber, D.F.; Wang, Y. Kinetic vs. thermodynamic control in intramolecular diene cyclozirconation: Synthesis of elemol. Tetrahedron Lett. 36: 6639 (1995).

90. Taber, D.F.; Meagley, R.P.; Louey, J.P.; Rheingold, A.L. Molecular complex design: Bridging the tetrakiscarboxylatodirhodium core. Inorg. Chim. Acta. 239: 25 (1995).

91. Taber, D.F.; Sahli, A.; Yu, H.; Meagley, R.P. Efficient intramolecular C-H insertion by an alkylidene carbene generated from a vinyl chloride. J. Org. Chem. 60: 6571 (1995).

92. Taber, D.F.; You, K.K.; Rheingold, A.L. Predicting the diastereoselectivity of Rh-mediated intramolecular C-H insertion. J. Am. Chem. Soc. 118: 547 (1996).

93. Yeola, S. N.; Saleh, S.A.; Brash, A.R.; Prakash, C.; Taber, D.F.; Blair, I.A. Synthesis of 10(S)-hydroxyeicosatetraenoic acid: A novel cytochrome P-450 metabolite of arachidonic acid. J. Org. Chem. 61: 838 (1996).

94. Taber, D.F.; Christos, T.E.; Hodge, C.N. Cyclohexenone annelation by alkylidene C-H insertion: Synthesis of oxo-T-cadinol. J. Org. Chem. 61: 2081 (1996).

95. Taber, D.F.; Meagley, R.P.; Supplee, D. A colorful Grignard reaction: Preparation of the triarylmethane dyes from 4-bromo N,N-dimethylaniline. J. Chem. Educ. 73: 259 (1996) (cover).

96. Taber, D.F.; Herr, R.J.; Pack, S.K.; Geremia, J.M. A convenient method for the preparation of (Z)-a,b-unsaturated carbonyl compounds. J. Org. Chem. 61: 2908 (1996).

97. Taber, D.F.; Meagley, R.P.; Doren, D.J. Cyclohexenone construction by intramolecular alkylidene C-H insertion: Synthesis of (+)-cassiol. J. Org. Chem. 61: 5723 (1996).

98. Taber, D.F.; Song, Y. Diastereoselective Rh-mediated construction of 2,3,5-trisubstituted tetrahydrofurans. J. Org. Chem. 61: 6706 (1996).

99. Taber, D.F.; Wang, Y., Liehr, S. Mini-scale oxidation/reduction in the organic laboratory course: 4-nitrobenzalehyde / 4-nitrobenzyl alcohol. J. Chem. Educ. 73: 1042 (1996).

100. Taber, D.F.; Song, Y. Stereocontrolled assembly of cis or trans angularly substituted hydrindenes by the unactivated intramolecular Diels-Alder reaction. J. Org. Chem. 61: 7507 (1996).

101. Taber, D.F.; Wang, Y. Synthesis of (-)-haliclonadiamine. J. Am. Chem. Soc. 119: 22 (1997).

102. Taber, D.F.; Herr, R.J.; Gleave, D.M. Diastereoselective synthesis of an isoprostane: (+/-)-8-epi-PGF2 ethyl ester. J. Org. Chem. 62: 194 (1997).

103. Taber, D.F.; Yu, H. Synthesis of a-necrodol: Unexpected formation of a cyclopropene J. Org. Chem. 62: 1687 (1997).

104. Taber, D.F.; Morrow, J.D.; Roberts, L.J.II A nomenclature system for the isoprostanes. Prostaglandins. 53: 63 (1997).

105. Taber, D.F.; Christos, T.E. Improved chemoselectivity in intramolecular alkylidene carbene insertion. Tetrahedron Lett. 38: 4927 (1997).

106. Taber, D.F.; Gorski, G.J.; Liable-Sands, L.M.; Rheingold, A.L. (R,R)-2,5-Diphenylpyrrolidine: Diastereoselective radical addition to the derived methacrylamide. Tetrahedron Lett. 38: 6317 (1997).

107. Taber, D.F.; Song, Y. Specific C-C bond construction by remote C-H activation: Synthesis of (-)-trans-cembranolide J. Org. Chem. 62: 6603 (1997).

108. Taber, D.F.; Kong, S. Alkylation of acetonitrile. J. Org. Chem. 62: 8575 (1997).

109. Taber, D.F.; Green, J.H.; Geremia, J.M. Carbon-carbon bond formation with allylmagnesium chloride. J. Org. Chem. 62: 9342 (1997).

110. Taber, D.F.; Weiss, Andrew J. Cinnamaldehyde by steam distillation of cinnamon. J. Chem. Educ. 75:633 (1998).

111. Taber, D.F.; Malcolm, Scott L. Rhodium-mediated intramolecular C-H insertion: Probing the geometry of the transition state. J. Org. Chem. 63: 3717 (1998).

112. Taber, D.F.; Stiriba, S.-E. Synthesis of natural products by rhodium-mediated intramolecular C-H insertion. Chem. Eur. J. 4: 990 (1998).

113. Taber, D.F.; Kanai, K. Synthesis of the four enantiomerically-pure isomers of 15-F2t-isoprostane. Tetrahedron 54: 11767(1998).

114. Taber, D.F.; Yu, H.; Szafraniec, L.L. Unexpected Double 18O Labeling of a Phosphonothioate. J. Org. Chem. 63: 5711 (1998).

115. Taber, D.F.; Kanai, K. A synthetic approach to 15-D2c-isoprostane ethyl ester J. Org. Chem. 63: 6607 (1998).

116. Taber, D.F.; Kong, S.; Malcolm, S.C. Internal Diels-Alder cycloaddition with a Z- dienophile: Synthesis of (±)-a-oplopenone J. Org. Chem. 63:7953 (1998).

117. Taber, D.F.; Yu, H.; Guzei, I.A.; Rheingold, A.L. Synthesis of (-)-isonitrin B. J. Am. Chem. Soc. 120: 13285 (1998).

118. Taber, D.F.; Malcolm, S.C.; Bieger, K.; Pahuerta, P.; Sanau, M.; Stiriba, S.-E.; Perez- Prieto, J.; Angeles-Monge, M. Synthesis, structure, and reactivity of the first enantiomerically pure ortho-metalated rhodium(II) dimer. J. Am. Chem. Soc. 121: 860 (1999).

119. Taber, D.F.; Nelson, J.D.; Northrop, J.P. Preparation and identification of benzoic acids and benzamides: An organic "unknown" lab. J. Chem. Educ. 76: 828 (1999).

120. Taber, D.F.; Christos, T.E.; Guzei, I.A.; Rheingold, A.L. Synthesis of (-)-fumagillin. J. Am. Chem. Soc. 121:5589 (1999).

121. Morrow, J.D.; Zackert, W.E.; Yang, J.P.; Kurhts, E.H.; Callewaert, D.; Dworski, R.; Kanai, K.; Taber, D.; Moore, K.; Oates, J.A.; Roberts, L.J. Quantification of the major urinary metabolite of 15-F2t isoprostane (8-isoPGF2a) by a stable isotope dilution mass spectometric assay. Analytical Biochem. 269: 326 (1999).

122. Taber, D.F.; Balijepalli, B.; Liu, K.-K.; Kong, S.; Rheingold, A.L.; Askham, F.R. Designing the chiral space around an early transition metal: Myrtanyl zirconocene J. Org. Chem. 64:4525 (1999).

123. Taber, D.F.; Kanai, K.; Pina, R. 5-F2t-Isoprostane, a human hormone? J. Am. Chem. Soc. 121:7773 (1999).

124. Taber, D.F.; Kanai, K. Synthesis of 2,3-dinor-5,6-dihydro-15F2t-isoprostane J. Org. Chem. 64:7983 (1999).

125. Taber, D.F.; Christos, T.E.; Neubert, T.D.; Batra, D. Cyclization of 1,1-disubstituted alkenes to cyclopentenes J. Org. Chem. 64:9673 (1999).

126. Taber, D.F.; Sethuraman, M. R. Unsymmetrical diaryl ketones from arenes J. Org. Chem. 65:254 (2000).

127. Taber, D.F.; Zhang, W.; Campbell, C.L.; Rheingold, A.R.; Incarvito, C.D. Cyclozirconation of a computationally-designed diene: Synthesis of (-)-androst-4-ene-3,16-dione J. Am. Chem. Soc.122:4813 (2000).

128. Taber, D.F.; Wang, Y.; Pahutski, T.F., Jr. Diastereoselective cyclopentane construction J. Org. Chem. 65: 3861 (2000).

129. Taber, D.F.; Kanai, K.; Jiang, Q.; Bui, G. Enantiomerically pure cyclohexenones by Fe-mediated carbonylation of alkenyl cyclopropanes J. Am. Chem. Soc. 122:6807 (2000).

130. Taber, D.F.; Yu, H. Drugs from Nature? Synthesis of the isonitrin antibiotics Science Progress 83: 135 (2000). 

131. Chenault, H.K.; Yang, J.; Taber, D.F. Total synthesis of a-deamino3-(b-D-glucopyranosyl)kynurenine. Tetrahedron 56: 3673 (2000).

132. Taber, D.F.; Green, J.H.; Zhang, W.; Song, R. Preparation of a cis-isoprostane synthon. J. Org. Chem. 65: 5436 (2000).

133. Taber, D.F.; Campbell, C.L.; Louey, J.P.; Wang, Y.; Zhang, W. Prediciting the diastereoselectivity of intramolecular diene cyclozirconation: Applications to natural product synthesis. Current Organic Chemistry 4: 809 (2000).

134. Taber, D.F.; Jiang, Q. Preparation of ent-prostaglandin E2. Tetrahedron 56: 5991 (2000).

135. Lahuerta, P.; Perez-Prieto, J.; Sanua, M.; Stiriba, S.E.; Taber, D.F. Ortho-metalated dirhodium(II)-catalyzed alpha-diazocarbonyl transformation. Diastereoselective cyclopropanation of menthyl-a-diazo-b-keto ester and C-H insertion of a-diazo ester. J. Organomet. Chem. 612: 36 (2000).

136. Taber, D.F.; Neubert, T.D. Enantioselective construction of cyclic quaternary centers: (-)-Mesembrine J. Org. Chem. 66:143 (2001).

137. Taber, D.F.; Malcolm, S.C. Synthesis of (-)-astrogorgiadiol J. Org. Chem. 66:94-953 (2001).

138. Taber, D.F.; Jiang, Q. Total synthesis of the four enantiomerically pure diastereomers of 8-F2t-isoprostane. J. Org. Chem. 66:1876-1884 (2001).

139. Taber, D.F.; Nakajima, K. Unsymmetrical ozonolysis of a Diels-Alder adduct: Practical preparation of a key intermediate for heme total synthesis. J. Org. Chem. 66:2515-2517 (2001).

140. Taber, D.F.; Bui, G.; Chen, B. Synthesis of (-)-delobanone. J. Org. Chem. 66:3423-3426 (2001).

141. Hou, X.; Roberts, J.L.; Taber, D.F.; Morrow, J.D.; Kanai, K.; Gobeil, F.; Beauchamp, M.H.; Bernier, S.G.; Lepage, G.; Varma, D.R.; Chemtob, S. 2,3-Dinor-5,6-dihydro-15-F-2t-isoprostane: a bioactive prostanoid metabolite. Am. J. Physiol. 281: R391-R400 (2001).

142. Taber, D.F.; Christos, T.E.; Rahimizadeh, M.; Chen, B. A convenient chiron for substituted cyclohexanones. J. Org. Chem. 66:5911-5914 (2001).

143. Taber, D.F.; Joshi, P.V. Free radical generation by reduction of ketone tosylhydrazones. C.R. Acad. Sci. Paris, Chimie 4: 557-560 (2001).

144. Taber, D.F.; Teng, D. Total synthesis of the ethyl ester of the major urinary metabolite of prostaglandin E2. J. Org. Chem. 67:1607-1612 (2002).

145. Taber, D.F.; Mitten, J.V. Preparation and reactions of 2-chloro-3,4-epoxy-1-butene: A convenient route to (Z)-3-chloroallylic alcohols. J. Org. Chem. 67: 3847-3851 (2002).

146. Taber, D.F.; Nakajima, K.; Xu, M.; Rheingold, A.L. Lactone-directed intramolecular Diels-Alder cyclization: Synthesis of trans-dihydroconfertifolin. J. Org. Chem. 67: 4501-4504 (2002).

147. Taber, D.F.; Jiang, Q.; Chen, B.; Zhang, W.; Campbell, C.L. Synthesis of (-)-Calicoferol B. J. Org. Chem. 67: 4821-4827 (2002).

148. Taber, D.F.; Neubert, T.D.; Rheingold, A.L. Synthesis of (-)-Morphine. J. Am. Chem. Soc. 124: 12416-17 (2002).

149. Taber, D.F.; Xu, M.; Hartnett, J.C. Synthesis of the eight enantiomerically-pure diastereomers of the 12-F2-Isoprostanes. J. Am. Chem. Soc. 124: 13121-13126 (2002).

150. Taber, D.F.; Storck, P.H. Linchpin construction of unsymmetrical 1,4-alkynediols. J. Org. Chem. 67: 8273-8275 (2002).

151. Taber, D.F.; Frankowski, K. J. Grubbs' catalyst in paraffin: An air-stable preparation for alkene metathesis. J. Org. Chem. 68: 6047-6048 (2003).

152. Taber, D.F.; Storck, P.J. Synthesis of (-)-tetrodotoxin: Preparation of an advanced cyclohexenone intermediate. J. Org. Chem. 68: 7768-7771 (2003).

153. Taber, D.F.; Hoerrner, R.S.; Herr, R,J,; Gleave, D.M.; Kanai, K.; Pina, R.; Jiang, Q.; Xu, M. The diazo ketone approach to the isoprostanes. Chem. Phys. Lipids 128: 57-67 (2004).

154. Hou, X.; Roberts, J.J. II; Gobeil, F. Jr.; Taber, D.F.; Kanai, K.; Abran, D.; Brault, S.; Checchin, D.; Sennlaub, F.; Lachapelle, P.; Varma, D.R.; Chemtob, S. Isomer-specific contractile effects of a series of synthetic F2-isoprostanes on retinal and cerebral microvasculature Free Radical Biol Med. 36:163-172 (2004).

 

 


Contributed Chapters

Taber, D.F.; Hennessy, M.J.; Hoerrner, R.S.; Raman, K.; Ruckle, R.E., Jr.; Schuchardt, J.S. Cyclopentane Construction by Rh-Catalyzed Intramolecular C-H Insertion: Scope and Selectivity. in Catalysis of Organic Reactions, Blackburn, D.W., Ed. Marcel Dekker, Inc., New York, 1990, pp. 43-60.

Taber, D.F. Carbon-Carbon Bond Formation by C-H Insertion. Comprehensive Organic Synthesis, V. 3, Pattenden, G. Ed., Pergamon Press, Oxford, 1991.

Taber, D.F.; Askani, R. Synthesis of Nitro, Nitroso and Related Compounds. Comprehensive Organic Synthesis, V. 6, Winterfeldt, E. Ed., Pergamon Press, Oxford, 1991.

Taber, D.F. Formation of C-C Bonds by C-H Insertion. Houben-Weyl, Methods of Organic Chemistry, V. E21, Helmchen, G. Ed., Georg Thiem Verlag, Stuttgart, 1995.

Books

Taber, D.F. Intramolecular Diels-Alder and Alder Ene Reactions, V. 18 of Reactivity and Structure Concepts in Organic Chemistry, Springer-Verlag, New York, 1984.

Bell, C.E., Jr.; Clark, A.K.; Taber, D.F.; Rodig, O.R. Organic Chemistry Laboratory: Standard & Microscale Experiments, Saunders College Publishing, Philadelphia, 1996.

Invited Lectures

1982

Johns Hopkins University, Baltimore, MD, October 13

Temple University, Philadelphia, PA, October 21

ICI Americas, Wilmington, DE, November 2

1983

NIADDK-NHLBI Organic Chemistry Discussion Group, Bethesda, MD January 4

Vanderbilt University, Nashville, TN, March 31

1984

Symposium, "Latest Trends in Organic Synthesis," Blacksburg, VA, May 30

Columbia University, New York, NY, July 5

Millersville University, Millersville, PA, October 10

Du Pont Experimental Station, Wilmington, DE, November 20

St. Joseph's University, Philadelphia, PA, November 28

1985

Rutgers, Newark, NJ, March 28

Schering Corporation, Bloomfield, NJ, April 17

Philadelphia Organic Chemists' Club, Philadelphia, PA, June 5

Tohoku College of Pharmacy, Sendai, Japan, July 9

University of Tokyo, Tokyo, Japan, July 17

Tokyo Institute of Technology, Tokyo, Japan, July 19

SUNY Stony Brook, Stony Brook, NY, October 3

CUNY, Queens College, Flushing, NY, October 23

Aberdeen Proving Ground, MD, October 30

University of Virginia, Charlottesville, VA, November 1

Dickinson College, Carlisle, PA, November 15

1986

College of William and Mary, Williamsburg, VA, Jan 17

Hoffmann-LaRoche, Nutley, NJ, January 23

Lederle Laboratories, Pearl River, NY, January 24

Sandoz Research Institute, East Hanover, NJ, March 31

University of Grenoble, Grenoble, France, May 23

ETH, Zurich, Switzerland, June 2

Ruprecht-Karls Univ., Heidelberg, W. Germany, June 4

University of Reims, Reims, France, June 5

Du Pont Central Research, Wilmington, DE, August 26

Susquehanna Valley Section, ACS, Wilkes-Barre, PA, October 8

Stuart Pharmaceuticals, Wilmington, DE, December 9

1987

Du Pont Biomedical Products, Wilmington, DE, March 25

Givaudan Corporation, Clifton, NJ, March 27

Bryn Mawr College, Bryn Mawr, PA, April 10

Middle Atlantic Regional Meeting, ACS, Pomona, NJ, May 19

American Cyanamid, Bound Brook, NJ June

Shippensburg University, Shippensburg, PA October 23

Du Pont Jackson Labs, Deepwater, NJ October 30

University of Rochester, Rochester, NY, December 2

1988

Pennsylvania State University, State College, PA, March 23

University of Houston, Houston, TX, April 22

Organic Reactions Catalysis Society, San Antonio, TX, April 25

Takasago International Corp., Tokyo, Japan, May 24

Tokyo Institute of Technology, Tokyo, Japan, May 25

Sagami Chemical Research Center, Kanagawa, Japan, May 27

Kyoto Institute of Technology, Kyoto, Japan, June 3

Kyushu Symposium on Natural Products Chemistry, Fukuoka, Japan, June 7

Kyushu University, Fukuoka, Japan, June 7

Du Pont Central Research, Wilmington, DE, September 23

Kansas State University, Manhattan, KS, November 3

University of Kansas, Lawrence, Kansas, November 4

1989

CRDCC, U. S. Army, Aberdeen, MD, January 19

Hunter College, New York, NY, March 3

Ciba-Geigy, Summit, NJ, April 6

Ciba-Geigy, Basel, Switzerland, May 9

Howard University, Washington, D.C., Sept. 15

SUNY, Binghamton, NY, October 20

Allergan, Inc., Irvine, CA,, November 3

Kyowa Hakko Co., Shizuoka, Japan, November 6

Nagoya University, Nagoya, Japan, November 7

International Symposium on Carbene Chemistry, Kyoto, Japan, Nov. 9

Southeast Regional Meeting, ACS, Baton Rouge, LA, December 7

1990

Lycoming College, Williamsport, PA, Feb. 14

UMBC, Baltimore, MD, March 6

Emory University, Atlanta, GA, April 17

Middle Atlantic Regional Meeting, ACS, Madison, NJ, May 23

Eli Lilly & Co., Indianapolis, IN, June 26

Rutgers University, Newark, NJ, October 11

University of Pennsylvania, Philadelphia, October 29

1991

New York Academy of Sciences, New York, NY Jan 8

Brigham Young University, Provo, Utah March 21

Hoffmann-La Roche, Basel, August 19

University of Basel August 20

University of Konstanz August 21

Academy of Sciences, Berlin, August 23

1992

Columbia University, New York, Jan 16

Dupont Central Research & Development, Feb 14

Allergan, Inc., Irvine, CA, 10 March

Stanford University, Stanford, CA April 22

ICI Americas, Richmond, CA April 23

Texas A&M, College Station, TX May 13

University of Monterrey, Mexico June 12

Adelphi University, Garden City, NY Sep 17

University of Maryland, College Park, MD Sep 22

Fordham University, Bronx, NY Oct. 20

Georgetown University, Washington, D.C. Oct.27

MARM-SERM Joint Regional Meeting, ACS, Crystal City, VA Dec 8

1993


E. Stroudsburg State Univ.; East Stroudsburg, PA
Feb. 2

ACS National Meeting, Denver, March 29

Peking University, Beijing, June 7

USA-Japan-China Symposium on Catalysis, Beijing,
June 10

Shanghai Institute of Organic Chemistry, June 16

Fudan University, Shanghai, June 17

SUNY Albany Oct 5

SUNY Stony Brook Oct 28

Scientific Conference on Chemical Defense Research, Aberdeen, MD Nov 18

1994

Syracuse University, Syracuse, NY Sep 20

Western Maryland College, November 28

SmithKline Beecham, King of Prussia, PA Dec 6

University of Delaware, Newark, DE Dec 7

1995

Syntex Pharmaceuticals, Palo Alto, CA April 20

University of California, Davis April 21

DuPont Central Research April 24

78th Canadian Society for Chemistry Conference and Exhibition, Guelph, May 31
(Invited speaker)

Drexel University, Philadelphia, PA June 7

Swarthmore College, Swarthmore, PA September 25

Dupont Merck Pharmaceuticals, Deepwater, NJ Oct 3

Rensselaer Polytechnic, Troy, NY Oct 12

GE Central Research, Schenectady, NY Oct 13

University of Victoria, Victoria, BC Oct 19

University of British Columbia, Vancouver, BC Oct 20

The Upjohn Company , Kalamazoo, Michigan Nov 10

1996

Towson State University, Towson, MD April 18

Middle Atlantic Regional Meeting, American Chemical Society, Villanova, PA, May 23 (Invited speaker)

SIPSYS, Avrille, France, June 25th

Ecole Nationale Superieure, Paris, June 26th

Gif-sur-Yvette, June 28th

International Conference on Organic Synthesis, Amsterdam, June 30- July 4 (Invited speaker)

14th Biennial Conference on Chemical Education, Clemson University, Aug 4-8 (Invited speaker)

Schering-Plough, Kenilworth, NJ, Sep. 26th

Abbott Labs, Chicago, IL, Nov. 7th

Rider College, Lawrenceville, NJ, Nov. 18th

1997

Pharmacopeia, Inc., Princeton, NJ Jan. 16th

Manhattan College, New York City, Jan. 22nd

North Jersey ACS Organic Section, Union College, Cranford, NJ April 28th

Southeast Regional Meeting, American Chemical Society, Roanoke, VA, Oct. 21 (Invited speaker)

IUPAC International Conference on Biodiversity and Bioresources, Phuket, Thailand, Nov. 23-27 (Invited speaker)

Rowan University, Glassboro, NJ December 2nd

1998

Dickinson College, Carlisle, PA March 5th

U. of Barcelona, Spain June 30th

Johnson-Matthey, West Deptford, NJ August 13th

ACS National Meeting, Boston, MA August 26th (Invited speaker)

Lafayette College, Easton, PA, September 8th

Bucknell University, Lewisburg, PA October 26th

Symposium, "Latest Trends in Organic Synthesis," Gainesville, FL Oct 31st

Wilkes University, Wilkes-Barre, PA November 12th

Smith Kline Beecham, November 17th

1999

University of Hong Kong January 15th

Chinese Uinversity of Hong Kong January 19th

University of Science and Technology, Hong Kong January 20th

Middle Atlantic Regional Meeting, American Chemical Society, May 17th (invited speaker)

Organometallics in Organic Synthesis (OMCOS), Versailles, France July 21st (invited speaker)

Gordon Research Conference on Natural Products, Henniker, NH July 26th (invited speaker)

University of Delaware, Newark, Sep. 17th

Elizabethtown College, Elizabethtown, PA Sept. 29th

Franklin & Marshall College, Lancaster, PA Sept. 29th

Florida State University, Tallahassee, Oct. 5

SERMACS (Southeast Regional Meeting), Knoxville, TN Oct. 19 (invited speaker)

Sloan-Kettering, New York, NY Oct. 26

Salisbury State University, Salisbury, MD Nov. 2

2000

National Institutes of Health, Bethesda, MD March 9

International Conference on Organic Synthesis, Warsaw, July 1- July 5 (Invited speaker)

Stockton State University, Pomona, NJ Oct. 9

Johns Hopkins University, Baltimore, MD Oct 10

2001

Brigham Young University, Provo, UT January 24th

Reed College, Portland, OR January 26th

Oregon State University, Corvallis, OR January 29th

Wyeth-Ayerst, Pearl River, NY March 29th

CB Research, New Castle, DE June 12th

OMCOS-11, Taipei, Taiwan July 23rd

Research Review, Center for Catalytic Science and Technology, University of Delaware, Oct.11th

Indiana U. of Pennsylvania, Indiana, PA Nov. 7th

Allegheny College, Meadville, PA Nov. 8th

Edinboro U. of Pennsylvania, Edinboro, PA Nov. 8th

Duquesne University, Pittsburgh, PA Nov. 9th

Ursinus College, Collegeville, PA Nov. 16th

2002

South China Agricultural University, Guangzhou, Jan. 7th.

Temple University, Philadephia, PA March 28

Sphinx Pharmaceuticals, Research Triangle Park, NC June 7th

UC Irvine, Sept. 12th

Scripps Institute, San Diego, CA Sept. 13th

CalTech, Pasadena, CA Sept. 16th.